Cargando…
Long-Term Management of Advanced Basal Cell Carcinoma: Current Challenges and Future Perspectives
SIMPLE SUMMARY: Local therapies are no longer an option for locally advanced basal cell carcinoma. Abnormal activation of the hedgehog signaling pathway leads to uncontrolled tumor growth. Hedgehog pathway inhibitors are an effective treatment option for this kind of tumor. However, treatment-relate...
Autores principales: | Heppt, Markus V., Gebhardt, Christoffer, Hassel, Jessica C., Alter, Mareike, Gutzmer, Ralf, Leiter, Ulrike, Berking, Carola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559463/ https://www.ncbi.nlm.nih.gov/pubmed/36230474 http://dx.doi.org/10.3390/cancers14194547 |
Ejemplares similares
-
Reinduction of Hedgehog Inhibitors after Checkpoint Inhibition in Advanced Basal Cell Carcinoma: A Series of 12 Patients
por: DeTemple, Viola K., et al.
Publicado: (2022) -
Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?
por: Wessely, Anja, et al.
Publicado: (2020) -
Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry
por: Haist, Maximilian, et al.
Publicado: (2022) -
Harmonisation of Outcome Parameters and Evaluation (HOPE) for actinic keratosis: protocol for the development of a core outcome set
por: Heppt, Markus V., et al.
Publicado: (2019) -
A Systematic Review and Meta-Analysis of Interventions for Actinic Keratosis from Post-Marketing Surveillance Trials
por: Steeb, Theresa, et al.
Publicado: (2020)